22th ESO Gastrointestinal Cancer Observatory: Forecast for colorectal cancer in the next 12 months
22th ESO Gastrointestinal Cancer Observatory: Forecast for colorectal cancer in the next 12 months
Chair: Sara De Dosso, CH
22th ESO Gastrointestinal Cancer Observatory: Forecast for colorectal cancer in the next 12 months
@ ESMO Gastrointestinal Cancers Congress 2026
Munich, Germany
When: Friday 3rd July, 2026 | 16:30 - 18:00
Where: Room: 5
The European School of Oncology is pleased to announce the 22th ESO Gastrointestinal Cancer Observatory: Forecast for colorectal cancer in the next 12 months, which will be held during the ESMO Gastrointestinal Cancers Congress 2026, in Munich, Gerany on 3 July 2026.
The scope of the session is to provide the participants with a take home message on what is the forecast for colorectal cancer in the next 12 months.
The Observatory takes place within the ESMO Gastrointestinal Cancers Congress 2026.
Participation in the Observatory is included in the registration to the conference.
03/07/2026 16:30
Welcome to the ESO session
03/07/2026 16:35
Welcome and introduction from the chairs and the past-President of ESMO
03/07/2026 16:40
The patient’s perspective
03/07/2026 16:55
The scientist’s perspective on exercise oncology
03/07/2026 17:10
The radiation oncologist's perspective
03/07/2026 17:25
The liver surgeon's perspective
03/07/2026 17:35
The medical oncologist's perspective
03/07/2026 17:50
Summary of the hottest topics in colorectal cancer in the next 12 months
Andrés Cervantes Ruiperez
University Clinical Hospital of Valencia (INCLIVA), Oncology Dept., Valencia, ES
Eric Van Cutsem
University Hospital Leuven, Digestive Oncology Dept., Leuven, BE
Jean - Nicolas Vauthey
UTMD Anderson Cancer Centre - University of Texas, Dept. of Surgical Oncology - Unit 444, Houston, US
Lasma Nikolaisone
., ., Riga, LV
Pedro Saint Maurice
Champalimaud Foundation, Breast Cancer Research Program, Lisbon, PT
Pierfrancesco Franco
University of Eastern Piedmont, Dept. of Translational Medicine, Novara, IT
Sara De Dosso
Oncology Institute of Southern Switzerland (IOSI), Medical Oncology Dpt., Bellinzona, CH
